SLC7A11 and lung carcinoma: TP53 promotes ferroptosis by transcriptionally repressing SLC7A11/xCT expression in lung cancer cells, while the TP53P47S variant suppresses SLC7A11 to a lesser extent, leading to tumor development54–56.